ABSTRACT MGI+D+, MGI+D-, and MGI-D-mouse myeloid leukemic cells, which genetically differ in their competence to be inducbd to undergo normal cell differentiation in vitro by the normal macrophage-and anulocyte-inducing irotein MGI, were analyzed for their afility to undergo cell differentiation in diffusion chambers in vivo. As after induction by MGI in vitro, MGI+D+ clones were induced for Fc and C3 rosettes, lysozyme, and mature macrophages and granulocytes in normal syngeneic or allogeneic mice. MGI+D-clones were also induced in these mice for all these properties, although in vitro they were not induced by MGI for mature cells. The MGI-D-clones were induced in vivo for C3 and Fc rosettes, lysozyme, and intermediate stages but not for mature cells, whereas none of these properties were induced in these clones by MGI in vitro. Thus, certain types of myeloid leukemic cells differentiate better in vivo, possibly due to the presence of higher effective concentrations of MGI and/or other inducing factors, and MGI+D+ and MGI+D-cells can completely differentiate in vivo to mature cells. In vivo differentiation was inhibited in mice treated with cyclophosphamide. It was also inhibited in various strains of nude mice, except for one MGI+D+ clone, where it was inhibited in C57BL/6 but not in ICR nude mice. This MGI+D+ clone was also the only clone that was induced to differentiate normally in vitro by a 23,000 molecular weight form of purified MGI. The results suggest that different clones respond to different molecular forms of MGI, which may be present in different proportions in some animals, that in vivo differentiation by MGI possibly with other factors may be regulated by cells involved in the immune response, and that this differentiation can be genetically controlled. Differentiation in vivo was enhanced by injection of conditioned medium containing MGI and by inoculation of MGI-roducing cells, including normal granulocytes. This indicates that the induction of normal differentiation of myeloid leukemic cells in vivo can be enhanced by these treatments. We have developed an in vitro system to study the controls that regulate growth and differentiation of normal (1-6) and leukemic (5-11) myeloid cells. The use of this system has shown that the normal macrophage-and granulocyte-inducing protein (2-4), which we now call MGI (6, 12), can induce in vitro normal precursor cells (2-6, 13) and some types of myeloid leukemic cells in mice (7-11) and humans (5) to undergo complete differentiation to mature macrophages or granulocytes. Mouse myeloid leukemic cell clones have been established that can be grown in culture as myeloblasts to promyelocytes, have a high leukemogenic capacity, and express different genetic blocks in differentiation (8-11). Some of these clones (MGI+D+) can be induced in vitro by purified MGI (7) to undergo differentiation to mature macrophages and granulocytes. This differentiation occurs via the normal differentiation sequence of induction of C3 and Fc rosettes (9, 14), C3-and Fc-mediated immune phagocytosis (10), and the synthesis and secretion of lysozyme (15 We have also studied the possibility of affecting the degree of in vtvo differentiation in myeloid leukemic cells by the injection of MGI or MGI-producing cells.
differentiation in diffusion chambers in vivo. As after induction by MGI in vitro, MGI+D+ clones were induced for Fc and C3 rosettes, lysozyme, and mature macrophages and granulocytes in normal syngeneic or allogeneic mice. MGI+D-clones were also induced in these mice for all these properties, although in vitro they were not induced by MGI for mature cells. The MGI-D-clones were induced in vivo for C3 and Fc rosettes, lysozyme, and intermediate stages but not for mature cells, whereas none of these properties were induced in these clones by MGI in vitro. Thus, certain types of myeloid leukemic cells differentiate better in vivo, possibly due to the presence of higher effective concentrations of MGI and/or other inducing factors, and MGI+D+ and MGI+D-cells can completely differentiate in vivo to mature cells. In vivo differentiation was inhibited in mice treated with cyclophosphamide. It was also inhibited in various strains of nude mice, except for one MGI+D+ clone, where it was inhibited in C57BL/6 but not in ICR nude mice. This MGI+D+ clone was also the only clone that was induced to differentiate normally in vitro by a 23,000 molecular weight form of purified MGI. The results suggest that different clones respond to different molecular forms of MGI, which may be present in different proportions in some animals, that in vivo differentiation by MGI possibly with other factors may be regulated by cells involved in the immune response, and that this differentiation can be genetically controlled. Differentiation in vivo was enhanced by injection of conditioned medium containing MGI and by inoculation of MGI-roducing cells, including normal granulocytes. This indicates that the induction of normal differentiation of myeloid leukemic cells in vivo can be enhanced by these treatments. We have developed an in vitro system to study the controls that regulate growth and differentiation of normal (1) (2) (3) (4) (5) (6) and leukemic (5-11) myeloid cells. The use of this system has shown that the normal macrophage-and granulocyte-inducing protein (2-4), which we now call MGI (6, 12) , can induce in vitro normal precursor cells (2) (3) (4) (5) (6) 13) and some types of myeloid leukemic cells in mice (7) (8) (9) (10) (11) and humans (5) to undergo complete differentiation to mature macrophages or granulocytes. Mouse myeloid leukemic cell clones have been established that can be grown in culture as myeloblasts to promyelocytes, have a high leukemogenic capacity, and express different genetic blocks in differentiation (8) (9) (10) (11) . Some of these clones (MGI+D+) can be induced in vitro by purified MGI (7) to undergo differentiation to mature macrophages and granulocytes. This differentiation occurs via the normal differentiation sequence of induction of C3 and Fc rosettes (9, 14) , C3-and Fc-mediated immune phagocytosis (10) , and the synthesis and secretion of lysozyme (15) . It results in the formation of mature cells which, like normal mature macrophages and granulocytes, no longer multiply in vitro and are no longer malignant in vivo (16) .
Other types of clones (MGI+D-) could be induced by MGI to form CS and Fc rosettes and lysozyme, with or without immune phagocytosis, but were not inducible for differentiation to mature cells; a third type of clone (MGI-D-) could not be induced in vitro by MGI for any of these properties (9, 11) . The normal macrophage and granulocyte protein inducer (1-4) that we now call MGI has also been referred to as mashran gm (17) , colony-stimulating factor (18) , or colony-stimulating activity (19) . (27) . MGI-Dclones 1 and 6 were from two independently arising myeloid leukemias in SJL/J mice (9, 10, 14) ; MGI+D+ clone 7-M12 was derived after mutagenesis from MGI-D-clone 7 (10) . The clone 1 used in these experiments differs from the clone 1 used previously (14) in that it now spontaneously has 6.2% Fc rosettes instead of 0.2% Fc rosettes. The cells were cultured in vitro in Eagle's medium with a 4-fold concentration of amino acids and vitamins (H-21, Grand Island Biological Co., Grand Island, NY) and 10% inactivated fetal calf serum. Conditioned medium containing MGI was obtained from the lungs of SL mice incubated for 2 days in Eagle's medium without serum as described (16) and from Krebs ascites cells incubated in spinner flasks for about 20 hr in Eagle's medium without serum at 5 X 106 cells per ml. Normal mature granulocytes were obtained from the peritoneal cavity of SL mice 16 hr after injection of 3 ml of sodium caseinate (Difco Lab., Detroit, M!) (28) .
Culture of Cells in Diffusion Chambers. The chambers were made as described (23) (12, 34, 35) ; MGI, molecular weight of about 23,000, has been purified from mouse lung conditioned medium (36) . The 68,000 molecular weight MGI can induce in vitro the differentiation of MGI+D+ clones such as 9 and 12 to mature macrophages and granulocytes (7) . However, the 23 (Fig. 2) . Similar inhibition was obtained with The chambers were harvested at 10 days after implantation. Mice were injected intraperitoneally with 200 mg of cyclophosphamide per kg 1 day before implantation of the chambers. Cyclophos., cyclophosphamide. Similar results were obtained with MGI+D+ clones 9 and 12 and MGI+D-clones 5 and 13. Lypozyme is expressed as ,ug equivalents per 5 X 106 cells.
termine whether this would enhance differentiation of clone 9 in normal mice and restore differentiation in abnormal syngeneic mice. Eight daily intraperitoneal injections of unconcentrated conditioned medium from syngeneic lungs or Krebs ascites cells into normal SL mice gave some enhancement of differentiation, so that there were only 3 ± 1% blast cells in the treated mice compared to 10 ± 2% blast cells in the controls (Table 4) . As expected, if the activity of this conditioned medium was due to MGI (37) , this enhancing effect of the conditioned medium was destroyed by trypsin. Injection of these conditioned media into cyclophosphamide-treated SL mice, in which there was a low level of differentiation, gave an increase in intermediate stages, some formation of mature cells, and about a 2-fold increase in lysozyme (Table 4) . Injections of medium without MGI activity did not induce any enhancement of differentiation.
Since the injected conditioned medium may not have remained for long in the peritoneal cavity, we either injected syngeneic normal granulocytes intraperitoneally into mice with a diffusion chamber or inplanted a double diffusion chamber (38) with the myeloid leukemic cells in one chamber and normal granulocytes or Krebs cells in the other chamber. These normal granulocytes (37) (16) , the formation of mature cells was associated with the stopping of cell multiplication. The results also show that MGI+D-cells, which did not form mature cells after incubation with MGI in vitro, formed mature cells in vivo, and that MGI-D-cells, which were not induced by MGI in vitro for any of the differentiation-associated properties tested, were induced for some of these properties in vivo. One possible explanation for these differences is that there may be in vivo a higher effective concentration of MGI than has been obtained in vitro and this may help to overcome some of the genetic blocks (10, 11, 32, 3) found under in vitro conditions. It has, however, also been shown that there are some other compounds,includingortain steroid hormones (10, 11, 14, 15) and lipopolysaccharides (39) , that can induce some differentiation-associated properties in cells with the appropriate genotype. One of the MGI-D-clones used, clone 6, can be induced for Fc rosettes by dexamethasone (14) . There appear to be different cellular sites for induction by different compounds (10, 11, 14 (25, 26) by injection of cyclophosphamide. The enhancement of the growth of cells associated with inhibition of differentiation in these mice could result from inhibition of differentiation and possibly also from changes in the levels of other stimulators or inhibitors of growth (42) . Differentiation in vivo of two out of three MGI+D+ clones was also inhibited in C57BL6 and ICR nude mice, but in one of the MGI+D+ clones (7-M12) differentiation was inhibited in C57BL6 nude but not in ICR nude mice. This was also the only clone that was induced to differentiate in vitro with the MGI of about 23 ,000 molecular weight purified from conditioned medium from mouse lungs (36) . MGI with molecular weight about 68,000 (12, 34, 35) , purified from fibroblast conditioned medium, induced normal differentiation (7) in MGI+D+ clones of the type that were not induced to differentiate by the MGI of about 23,000 molecular weight. All the clones were also induced to differentiate normally in vitro by unfractionated conditioned medium from mouse lungs. This suggests that some abnormal animals may have a relative deficiency of the higher molecular weight form of MGI or of cofactors (12, 34) that may be required for differentiation. We suggest, from the present results, that the induction of in vivo differentiation by MGI of different molecular weights possibly with other factors, may be regulated by cells involved in the immune response whose functions can be impaired in nude or cyclophosphamide-treated mice, and that this regulation can be genetically controlled.
The results have also shown that the differentiation of leukemic cells in vvo could be enhanced by injection of conditioned medium containing MGI, and even better, by inoculation of MGI-producing cells, including normal granulocytes. The extension of these findings to humans could have considerable implications for the treatment of myeloid leukemia (5-7, 11,43) .
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